Graphene-Based Neural Probes Probe Brain Activity in High Resolution
March 30, 2017 | Graphene FlagshipEstimated reading time: 3 minutes
Measuring brain activity with precision is essential to developing further understanding of diseases such as epilepsy and disorders that affect brain function and motor control. Neural probes with high spatial resolution are needed for both recording and stimulating specific functional areas of the brain. Now, researchers from the Graphene Flagship have developed a new device for recording brain activity in high resolution while maintaining excellent signal to noise ratio (SNR). Based on graphene field-effect transistors, the flexible devices open up new possibilities for the development of functional implants and interfaces.
The Graphene Flagship’s Biomedical Technologies Work Package explores the use of graphene and related materials in biomedical implant devices such as neural implants for recording and stimulating electrical activity, and targeted drug delivery. Graphene’s biocompatibility, chemical stability and flexibility – alongside its excellent electrical properties – make it attractive for use in medical devices. “Mechanical compliance is an important requirement for safe neural probes and interfaces,” said Jose Antonio Garrido, who led the research at ICN2. “Currently, the focus is on ultra-soft materials that can adapt conformally to the brain surface.”
Measuring brain activity
The devices were used to record the large signals generated by pre-epileptic activity in rats, as well as the smaller levels of brain activity during sleep and in response to visual light stimulation. These types of activities lead to much smaller electrical signals, and are at the level of typical brain activity. The graphene transistor probes showed excellent performance, with a high SNR and good spatial discrimination of the brain activity.
Neural activity is detected through the electric fields generated when neurons fire. These fields are highly localised, so having ultra-small measuring devices that can be densely packed is important for accurate brain readings. The graphene-based probes are competitive with state-of-the-art platinum electrode arrays and have the benefits of intrinsic signal amplification and a better signal-to-noise performance when scaled down to very small sizes. This will allow for more densely packed and higher resolution probes, vital for precision mapping of brain activity. The inherent amplification property of the transistor also removes the need for a preamplification close to the probe – a requirement for metal electrodes.
Graphene neural probes
The neural probes are placed directly on the surface of the brain, so safety is of paramount importance for the development of graphene-based neural implant devices. “Graphene is one of the few materials that allows recording in a transistor configuration and simultaneously complies with all other requirements for neural probes such as flexibility, biocompability and chemical stability.” said Benno Blaschke of TU Munich, first author of the research. Importantly, the researchers determined that the graphene-based probes are non-toxic, and did not induce any significant inflammation. Graphene-containing implants should be long-lasting and safe – key characteristics of long-term therapeutic devices.
An array of 16 graphene-based transistors, each with an active area less than the cross section of a human hair, are arranged on a flexible substrate to form the probe. “Although graphene is ideally suited for flexible electronics, it was a great challenge to transfer our fabrication process from rigid substrates to flexible ones,” said Blaschke. “The next step is to optimize the wafer-scale fabrication process and improve device flexibility and stability.”
Future implant technology
This work represents a first step towards the use of graphene in research as well as clinical neural devices, showing that graphene-based technologies can deliver the high resolution and high SNR needed for these applications. “Graphene neural interfaces have shown already a great potential, but we have to improve on the yield and homogeneity of the device production in order to advance towards a real technology,” said Garrido, who is also the Deputy of the Graphene Flagship Biomedical Technologies work package. “Once we have demonstrated the proof of concept in animal studies, the next goal will be to work towards the first human clinical trial with graphene devices during intraoperative mapping of the brain. This means addressing all regulatory issues associated to medical devices such as safety, biocompatibility, etc.”
Devices implanted in the brain as neural prosthesis for therapeutic brain stimulation technologies and interfaces for sensory and motor devices, such as artificial limbs, are an important goal for improving quality of life for patients. Andrea Ferrari, Science and Technology Officer and Chair of the Management Panel of the Graphene Flagship, added "We are pleased to see this promising result from the newly formed work-package on Biomedical Technologies. This was created to exploit the short and long term potential of graphene and related materials in this high growth area, with great potential benefits for society."
Suggested Items
LQDX Divests Aluminum Soldering Business - Mina™ - to Taiyo America Inc.
05/02/2024 | PRNewswireLQDX, formerly known as Averatek Corp., developer of high-performance materials for advanced semiconductor manufacturing, today announced that it has divested its aluminum soldering business – known as MinaTM – to Taiyo America Inc., a global market leader in advanced electronic materials.
Indium Corporation Expert to Present on Pb-Free Solder for Die-Attach in Discrete Power Applications
04/30/2024 | Indium CorporationIndium Corporation Product Manager – Semiconductor Dean Payne will present at the Advanced Packaging for Power Electronics conference, hosted by IMAPS, held May 8-9 in Woburn, Massachusetts, USA.
Real Time with... IPC APEX EXPO 2024: Adhesive Materials and Equipment Update with Dymax
05/01/2024 | Real Time with...IPC APEX EXPOVirginia Hogan, global business development manager at Dymax, discusses adhesive materials, dispensing and curing equipment, a new, high-reliability conformal coating, and various materials and dispensing methods.
Real Time with... IPC APEX EXPO 2024: Sustainability in the Industry
04/26/2024 | Real Time with...IPC APEX EXPOGuest Editor Henry Crandall and Chris Nash of Indium Corporation discuss the company's 90th anniversary and its focus on sustainability. They focus on the benefits of sustainable materials, their compatibility, and value propositions. The conversation also highlights how Durafuse LT technology's role in reducing reflow temperatures is leading to significant cost and energy savings. Nash also touches on downstream sustainability efforts such as using recycled materials for packaging.
SMC Korea 2024 to Highlight Semiconductor Materials Trends and Innovations on Industry’s Path to $1 Trillion
04/24/2024 | SEMIWith Korea a major consumer of semiconductor materials and advanced materials a key driver of innovation on the industry’s path to $1 trillion, industry leaders and experts will gather at SMC (Strategic Materials Conference) Korea 2024 on May 29 at the Suwon Convention Center in Gyeonggi-do, South Korea to provide insights into the latest materials developments and trends. Registration is open.